Subscribe To
Cingulate to Host CNS Key Opinion Leader Panel in New York City

Expert Analysis of Cingulate, its Phase 3 ADHD Adult Data, Anxiety, and PTR™ Drug Delivery Platform Innovations KANSAS CITY, Kan., Oct. 17, 2023 (GLOBE NEWSWIRE) — Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products, announced today […] The post Cingulate to Host CNS Key Opinion Leader Panel in New York City appeared first o...
Read More
Posted: Oct 17 2023, 18:22
Author Name: forextv
Views: 082464